MAZZONE, CARLA
MAZZONE, CARLA
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies
2024-10-01 Niscola, P; Gianfelici, V; Catalano, G; Giovannini, M; Mazzone, C; Noguera, Ni; DE FABRITIIS, P
Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient
2023-05-17 Niscola, P; Mazzone, C; Fratoni, S; Ardu, Nr; Cesini, L; Giovannini, M; Ottone, T; Anemona, L; Voso, Mt; de Fabritiis, P
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
2021-06-28 Molica, M; Perrone, S; Mazzone, C; Niscola, P; Cesini, L; Abruzzese, E; de Fabritiis, P
Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances
2023-12-20 Canichella, M; Molica, M; Mazzone, C; de Fabritiis, P
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
2022-06-08 Molica, M; Perrone, S; Mazzone, C; Cesini, L; Canichella, M; de Fabritiis, P
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy
2019-01-01 Niscola, P; Noguera, Ni; Catalano, G; Cupelli, L; Fratoni, S; Giovannini, M; Mazzone, C; Neri, B; Scaramucci, L; Trawinska, Mm; de Fabritiis, P; Abruzzese, E
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib
2021-01-01 Molica, M; Mazzone, C; Cordone, I; Divona, M; Niscola, P; de Fabritiis, P
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial
2016-03-20 Amadori, S; Suciu, S; Selleslag, D; Aversa, F; Gaidano, G; Musso, M; Annino, L; Venditti, A; Voso, Mt; Mazzone, C; Magro, D; DE FABRITIIS, P; Muus, P; Alimena, G; Mancini, M; Hagemeijer, A; Paoloni, F; Vignetti, M; Fazi, P; Meert, L; Ramadan, S; Willemze, R; de Witte, T; Baron, F
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
2022-10-06 Molica, M; Mazzone, C; Niscola, P; Carmosino, I; Di Veroli, A; De Gregoris, C; Bonanni, F; Perrone, S; Cenfra, N; Fianchi, L; Piccioni, Al; Spadea, A; Luzi, G; Mengarelli, A; Cudillo, L; Maurillo, L; Pagano, L; Breccia, M; Rigacci, L; De Fabritiis, P
Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms
2024-04-19 Niscola, P; Gianfelici, V; Giovannini, M; Piccioni, D; Mazzone, C; de Fabritiis, P
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
2019-01-01 Niscola, P; Grazia, Cd; Mazzone, C; Tolu, B; De Fabritiis, P; Angelucci, E
Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
2024-10-10 Canichella, M; Molica, M; Mazzone, C; de Fabritiis, P
New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine
2021-06-01 Niscola, P; Mazzone, C; Molica, M; de Fabritiis, P
Quality of life considerations in myelodysplastic syndrome: not only fatigue
2024-08-01 Niscola, P; Gianfelici, V; Giovannini, M; Piccioni, D; Mazzone, C; de Fabritiis, P
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies
2020-07-01 Molica, M; Mazzone, C; Cordone, I; Pasquale, A; Niscola, P; de Fabritiis, P
TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
2020-01-01 Molica, M; Mazzone, C; Niscola, P; de Fabritiis, P
Utilizzo di sangue periferico come fonte alternativa al sangue midollare per il monitoraggio della malattia minima residua nella Leucemia Mieloide Acuta
2009-01-15 Mazzone, Carla
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-ott-2024 | Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies | Niscola, P; Gianfelici, V; Catalano, G; Giovannini, M; Mazzone, C; Noguera, Ni; DE FABRITIIS, P | Articolo su rivista | |
| 17-mag-2023 | Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient | Niscola, P; Mazzone, C; Fratoni, S; Ardu, Nr; Cesini, L; Giovannini, M; Ottone, T; Anemona, L; Voso, Mt; de Fabritiis, P | Articolo su rivista | |
| 28-giu-2021 | CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin | Molica, M; Perrone, S; Mazzone, C; Niscola, P; Cesini, L; Abruzzese, E; de Fabritiis, P | Articolo su rivista | |
| 20-dic-2023 | Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances | Canichella, M; Molica, M; Mazzone, C; de Fabritiis, P | Articolo su rivista | |
| 8-giu-2022 | CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML | Molica, M; Perrone, S; Mazzone, C; Cesini, L; Canichella, M; de Fabritiis, P | Articolo su rivista | |
| 1-gen-2019 | Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy | Niscola, P; Noguera, Ni; Catalano, G; Cupelli, L; Fratoni, S; Giovannini, M; Mazzone, C; Neri, B; Scaramucci, L; Trawinska, Mm; de Fabritiis, P; Abruzzese, E | Articolo su rivista | |
| 1-gen-2021 | Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib | Molica, M; Mazzone, C; Cordone, I; Divona, M; Niscola, P; de Fabritiis, P | Articolo su rivista | |
| 20-mar-2016 | Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial | Amadori, S; Suciu, S; Selleslag, D; Aversa, F; Gaidano, G; Musso, M; Annino, L; Venditti, A; Voso, Mt; Mazzone, C; Magro, D; DE FABRITIIS, P; Muus, P; Alimena, G; Mancini, M; Hagemeijer, A; Paoloni, F; Vignetti, M; Fazi, P; Meert, L; Ramadan, S; Willemze, R; de Witte, T; Baron, F | Articolo su rivista | |
| 6-ott-2022 | Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience | Molica, M; Mazzone, C; Niscola, P; Carmosino, I; Di Veroli, A; De Gregoris, C; Bonanni, F; Perrone, S; Cenfra, N; Fianchi, L; Piccioni, Al; Spadea, A; Luzi, G; Mengarelli, A; Cudillo, L; Maurillo, L; Pagano, L; Breccia, M; Rigacci, L; De Fabritiis, P | Articolo su rivista | |
| 19-apr-2024 | Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms | Niscola, P; Gianfelici, V; Giovannini, M; Piccioni, D; Mazzone, C; de Fabritiis, P | Articolo su rivista | |
| 1-gen-2019 | Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation | Niscola, P; Grazia, Cd; Mazzone, C; Tolu, B; De Fabritiis, P; Angelucci, E | Articolo su rivista | |
| 10-ott-2024 | Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia | Canichella, M; Molica, M; Mazzone, C; de Fabritiis, P | Articolo su rivista | |
| 1-giu-2021 | New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine | Niscola, P; Mazzone, C; Molica, M; de Fabritiis, P | Articolo su rivista | |
| 1-ago-2024 | Quality of life considerations in myelodysplastic syndrome: not only fatigue | Niscola, P; Gianfelici, V; Giovannini, M; Piccioni, D; Mazzone, C; de Fabritiis, P | Articolo su rivista | |
| 1-lug-2020 | SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies | Molica, M; Mazzone, C; Cordone, I; Pasquale, A; Niscola, P; de Fabritiis, P | Articolo su rivista | |
| 1-gen-2020 | TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge? | Molica, M; Mazzone, C; Niscola, P; de Fabritiis, P | Articolo su rivista | |
| 15-gen-2009 | Utilizzo di sangue periferico come fonte alternativa al sangue midollare per il monitoraggio della malattia minima residua nella Leucemia Mieloide Acuta | Mazzone, Carla | Tesi di dottorato |